Exane Asset Management acquired a new position in Davita Inc (NYSE:DVA) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,753 shares of the company’s stock, valued at approximately $296,000.

Other hedge funds also recently made changes to their positions in the company. Quantamental Technologies LLC bought a new stake in Davita in the fourth quarter worth about $34,000. Honkamp Krueger Financial Services Inc. bought a new stake in shares of Davita in the third quarter valued at approximately $143,000. Dupont Capital Management Corp raised its position in shares of Davita by 41.0% in the fourth quarter. Dupont Capital Management Corp now owns 2,525 shares of the company’s stock valued at $130,000 after purchasing an additional 734 shares during the period. Atlas Capital Advisors LLC raised its position in shares of Davita by 247.9% in the third quarter. Atlas Capital Advisors LLC now owns 2,592 shares of the company’s stock valued at $188,000 after purchasing an additional 1,847 shares during the period. Finally, Captrust Financial Advisors raised its position in shares of Davita by 96.8% in the third quarter. Captrust Financial Advisors now owns 3,050 shares of the company’s stock valued at $218,000 after purchasing an additional 1,500 shares during the period. 85.99% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently issued reports on DVA. Raymond James lowered shares of Davita from a “strong-buy” rating to a “market perform” rating in a research report on Thursday, November 8th. TheStreet lowered shares of Davita from a “b-” rating to a “c+” rating in a research report on Thursday, November 8th. Royal Bank of Canada boosted their price target on shares of Davita from $70.00 to $78.00 and gave the company a “sector perform” rating in a research report on Thursday, November 8th. ValuEngine lowered shares of Davita from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th. Finally, Zacks Investment Research lowered shares of Davita from a “hold” rating to a “sell” rating in a research report on Tuesday, November 13th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $71.93.

Shares of NYSE:DVA opened at $56.13 on Monday. The company has a market cap of $9.32 billion, a P/E ratio of 16.91, a PEG ratio of 0.57 and a beta of 1.31. Davita Inc has a 12 month low of $48.25 and a 12 month high of $79.11. The company has a debt-to-equity ratio of 2.09, a current ratio of 1.84 and a quick ratio of 1.82.

COPYRIGHT VIOLATION WARNING: “5,753 Shares in Davita Inc (DVA) Acquired by Exane Asset Management” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.thecerbatgem.com/2019/02/11/5753-shares-in-davita-inc-dva-acquired-by-exane-asset-management.html.

Davita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also: What is the downside to momentum investing?

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.